Avaleht › 2. tüüpi diabeet › Pennsylvania
2. tüüpi diabeet kliinilised uuringud osariigis Pennsylvania
30 uuringut haiguse 2. tüüpi diabeet jaoks otsivad osalejaid osariigis Pennsylvania.
Linnad osariigis Pennsylvania
Ametlik uuringutekst (inglise keeles)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Heritage Valley Medical Group, Beaver
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07564414EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Heritage Valley Medical Group, Beaver
- Capital Area Research, LLC, Camp Hill
- Thomas Jefferson University, Philadelphia
- ja veel 8
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Heritage Valley Medical Group, Beaver
- Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
- Preferred Primary Care Physicians, Pittsburgh
- ja veel 1
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Capital Area Research, Camp Hill
VärbamineTerved vabatahtlikud oodatud
Vanused 55 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Smithfield
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
- Preferred Primary Care Physicians, Uniontown
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Scottdale
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Phenotyping Genetic Risk for Type 2 Diabetes
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
VärbamineTerved vabatahtlikud oodatud
Vanused 10–70 · Kõik sood · Uuendatud 21. sept 2026 · NCT04024631A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Philadelphia
- AURORA-2 Clinical Site, Pittsburgh
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- VA Pittsburgh Healthcare System, Pittsburgh
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Frontier Clinical Research, LLC, Scottdale
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 14. sept 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Northeast Clinical Research Center, Bethlehem
- Suburban Research Associates, West Chester
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 11. sept 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Preferred Primary Care Physicians, Inc., Uniontown
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 11. sept 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Feasterville-Trevose
- Research Site, Philadelphia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Suburban Research Associates, West Chester
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07296484A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Children's Hosptl Philadelphia, Philadelphia
VärbamineFaas 3
Vanused 10–18 · Kõik sood · Uuendatud 9. sept 2026 · NCT07282613AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Heritage Valley Medical Group, Beaver
- Capital Area Research LLC, Newport
VärbamineFaas 3
Vanused 45 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07797335A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 7. aug 2026 · NCT06739122The GRoceries Aimed at Increasing Nutrition Study
- University of Pennsylvania, Philadelphia
VärbamineOsalejatele makstakse tasu
Vanused 45–70 · Kõik sood · Uuendatud 6. aug 2026 · NCT07167004Pharmacogenetics of Response to GLP1R Agonists
- Amish Research Clinic, Lancaster
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–89 · Kõik sood · Uuendatud 27. juuli 2026 · NCT05071898CGM for Management of Type 2 Diabetes in Pregnancy
- University of Pennsylvania, Philadelphia
Värbamine
Vanused 18–50 · Naised · Uuendatud 29. juuni 2026 · NCT06628453Sleep and Glycemic Control in Type 2 Diabetes Adolescents
- Children's Hospital of Philadelphia, Philadelphia
Värbamine
Vanused 12–20 · Kõik sood · Uuendatud 29. juuni 2026 · NCT04213547DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Children's Hospital of Philadelphia, Philadelphia
VärbamineVaatlusuuring
Vanused 8–15 · Kõik sood · Uuendatud 7. mai 2026 · NCT06525259Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
VärbamineTerved vabatahtlikud oodatud
Vanused 13 ja vanemad · Kõik sood · Uuendatud 27. apr 2026 · NCT07216118Transformative Research in Diabetic Nephropathy 2.0
- Penn Presbyterian Medical Center, Philadelphia
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. märts 2026 · NCT07444203Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
- Children's Hospital of Pittsburgh, Pittsburgh
Värbamine
Vanused 16–24 · Kõik sood · Uuendatud 20. veebr 2026 · NCT07270016Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 12–17 · Kõik sood · Uuendatud 18. dets 2025 · NCT05277558CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
- Thomas Jefferson University, Philadelphia
Värbamine
Vanused 18 ja vanemad · Naised · Uuendatud 14. okt 2025 · NCT07184775Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
- Reading Hospital, an affiliate of Tower Health, West Reading
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. juuli 2025 · NCT05893927Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.